Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ecopetrol SA

8.15
+0.09001.12%
Post-market: 8.180.0300+0.37%18:22 EDT
Volume:3.71M
Turnover:29.88M
Market Cap:16.76B
PE:4.95
High:8.21
Open:8.19
Low:7.95
Close:8.06
Loading ...

Ecopetrol (EC) Stock Sinks As Market Gains: What You Should Know

Zacks
·
Yesterday

Meta Expects Worse User Experience for Europeans After EC Decision -- Market Talk

Dow Jones
·
01 May

Why Ecopetrol S.A. (EC) Stock is Falling This Week

Insider Monkey
·
30 Apr

Avnet Reports Third Quarter 2025 Financial Results

Business Wire
·
30 Apr

TG Therapeutics to Host Conference Call on First Quarter 2025 Financial Results and Business Update

GlobeNewswire
·
30 Apr

Ionis reports first quarter 2025 financial results

Business Wire
·
30 Apr

ArcelorMittal S.A.: ArcelorMittal reports first quarter 2025

GlobeNewswire
·
30 Apr

Equinor to commence second tranche of the 2025 share buy-back programme

GlobeNewswire
·
30 Apr

Is Ecopetrol S.A. (EC) a Small-Cap Energy Stock Hedge Funds Are Buying?

Insider Monkey
·
30 Apr

Gilead to Present Latest Advancements Across Primary Biliary Cholangitis and Viral Hepatitis

Business Wire
·
29 Apr

Pfizer Reports Solid First-Quarter 2025 Results And Reaffirms 2025 Guidance

Business Wire
·
29 Apr

Travere, CSL Vifor announce EC approval of Filspari marketing authorization

TIPRANKS
·
29 Apr

Ecopetrol Gets Approval for $500 Million Loan Deal With Banco Santander

MT Newswires Live
·
29 Apr

Ecopetrol gets authorization to execute $500M loan

TIPRANKS
·
29 Apr

Press Release: Ecopetrol S.A. obtains authorization to execute a loan agreement with an international bank for five hundred million dollars

Dow Jones
·
29 Apr

GENFIT: positive late-breaking Phase 2 data for elafibranor in Primary Sclerosing Cholangitis (PSC) to be presented by Ipsen at EASL Congress 2025

GlobeNewswire
·
29 Apr

Regeneron Pharmaceuticals (NasdaqGS:REGN) Gains Conditional EC Approval For Lynozyfic In Multiple Myeloma

Simply Wall St.
·
29 Apr

Halozyme Announces argenx Received Positive CHMP Opinion for VYVGART® (efgartigimod alfa) Subcutaneous Injection with ENHANZE® for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

PR Newswire
·
28 Apr

Lynozyfic™ (linvoseltamab) Approved in the European Union for the Treatment of Relapsed/Refractory Multiple Myeloma

GlobeNewswire
·
28 Apr

Krystal Biotech Announces European Commission Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa

GlobeNewswire
·
28 Apr